- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
ARCHIVE Published on: 2006-01-01
End Federal Raids
The journal Neurology published the results of a clinical trial indicating that smoked marijuana effectively reduces chronic pain for people living with HIV/AIDS. The study builds on other international evidence and the federal government's own 1999 Institute of Medicine (IOM) report, Marijuana and Medicine-Assessing the Science, which firmly stated that marijuana has medical value and made several recommendations for further study. To date the federal government has never undertaken any effort to review or implement these recommendations. Until the federal government moves forward with a review of the IOM recommendations, and initiates and completes research of the medical efficacy of marijuana, the States should not be obstructed from being responsive to the public health needs of its citizens.
Despite the extent of scientific studies, government reports and journal articles from around the world that support the medical value of marijuana, the US Department of Justice has been conducting paramilitary style raids on dozens of bona-fide medical cannabis patient collectives across the state of California. These attacks have become more frequent since the U.S. Supreme Court's decision in Gonzales v. Raich, which upheld DEA's authority to conduct raids, but questioned the wisdom of doing so.
The fiscal impact of these raids yet to be determined, but despite increased enforcement efforts, medical cannabis collectives continue to open throughout California, Colorado, Washington, and in other medical cannabis jurisdictions. The Rohrabacher-Farr Medical Marijuana Amendment seeks to put scarce federal law enforcement resources to better use. The amendment specifically prohibits the Department of Justice from using appropriated funds to interfere with the implementation of medical cannabis laws in 40 states that have approved such use.
WHAT IS THE ROHRABACHER-FARR AMENDMENT?
- The Rohrabacher-Farr Amendment prohibits any funds made available in the Act to the Department of Justice from being used to prevent states and territories from implementing State laws authorizing the use of medical marijuana in those States.
- The Rohrabacher-Farr Amendment does not "legalize" medical cannabis. It simply limits the federal government's ability to raid and prosecute medical cannabis patients and providers who are abiding by their state law.
WHY IS THE ROHRABACHER-FARR AMENDMENT NEEDED?
- Between FY2005 and FY2015, the DEA has conducted hundreds of raids on legal and registered patient collectives and dispensaries across the state of California. Currently, the Department of Justice (DOJ) is prosecuting more than three-dozen licensed medical cannabis patients and care providers.
- The federal government has failed to implement any of the recommendations provided by the National Academy of Science's 1999 Institute of Medicine (IOM) report, Marijuana and Medicine: Assessing the Science Base. Until the Administration provides access to cannabis for research and therapeutic use, Congress should limit the ability of DOJ to arrest and prosecute patients and providers who are acting within the limits of their state law.